Transferrin-bearing dendrimers for cancer therapy: an update

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Recent advances in multi-disciplinary research have resulted in the emergence of an increasing number of promising therapeutic strategies against cancer. However, the intravenous administration of these drugs is often limited by their inability to specifically reach the tumors, thus resulting in damaging secondary effects on healthy tissues. In order to remediate to this problem, a wide range of delivery systems have been investigated, aiming to specifically target the cancer cells and deliver their cargo to the pathological site. Among them, transferrin-bearing dendrimers are emerging as highly promising non-viral vectors for efficiently delivering drugs and nucleic acids to the cancer cells. The focus of this editorial is to provide an update on the therapeutic advances being made so far when using these targeted delivery systems.
LanguageEnglish
Pages2125-2127
Number of pages3
JournalNanomedicine
Volume10
Issue number14
DOIs
Publication statusPublished - Jul 2015

Fingerprint

Bearings (structural)
Dendrimers
Transferrin
Cells
Nucleic acids
Pharmaceutical Preparations
Nucleic Acids
Tumors
Neoplasms
Tissue
Therapeutics
Intravenous Administration
Research

Keywords

  • dendrimer
  • nanomedicine
  • transferrin
  • tumor targeting
  • gene therapy

Cite this

@article{d7e60a0c472346ce958e8042d58387e7,
title = "Transferrin-bearing dendrimers for cancer therapy: an update",
abstract = "Recent advances in multi-disciplinary research have resulted in the emergence of an increasing number of promising therapeutic strategies against cancer. However, the intravenous administration of these drugs is often limited by their inability to specifically reach the tumors, thus resulting in damaging secondary effects on healthy tissues. In order to remediate to this problem, a wide range of delivery systems have been investigated, aiming to specifically target the cancer cells and deliver their cargo to the pathological site. Among them, transferrin-bearing dendrimers are emerging as highly promising non-viral vectors for efficiently delivering drugs and nucleic acids to the cancer cells. The focus of this editorial is to provide an update on the therapeutic advances being made so far when using these targeted delivery systems.",
keywords = "dendrimer, nanomedicine, transferrin, tumor targeting, gene therapy",
author = "Sukrut Somani and Christine Dufes",
year = "2015",
month = "7",
doi = "10.2217/nnm.15.93",
language = "English",
volume = "10",
pages = "2125--2127",
journal = "Nanomedicine",
issn = "1743-5889",
number = "14",

}

Transferrin-bearing dendrimers for cancer therapy : an update. / Somani, Sukrut; Dufes, Christine.

In: Nanomedicine, Vol. 10, No. 14, 07.2015, p. 2125-2127.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Transferrin-bearing dendrimers for cancer therapy

T2 - Nanomedicine

AU - Somani, Sukrut

AU - Dufes, Christine

PY - 2015/7

Y1 - 2015/7

N2 - Recent advances in multi-disciplinary research have resulted in the emergence of an increasing number of promising therapeutic strategies against cancer. However, the intravenous administration of these drugs is often limited by their inability to specifically reach the tumors, thus resulting in damaging secondary effects on healthy tissues. In order to remediate to this problem, a wide range of delivery systems have been investigated, aiming to specifically target the cancer cells and deliver their cargo to the pathological site. Among them, transferrin-bearing dendrimers are emerging as highly promising non-viral vectors for efficiently delivering drugs and nucleic acids to the cancer cells. The focus of this editorial is to provide an update on the therapeutic advances being made so far when using these targeted delivery systems.

AB - Recent advances in multi-disciplinary research have resulted in the emergence of an increasing number of promising therapeutic strategies against cancer. However, the intravenous administration of these drugs is often limited by their inability to specifically reach the tumors, thus resulting in damaging secondary effects on healthy tissues. In order to remediate to this problem, a wide range of delivery systems have been investigated, aiming to specifically target the cancer cells and deliver their cargo to the pathological site. Among them, transferrin-bearing dendrimers are emerging as highly promising non-viral vectors for efficiently delivering drugs and nucleic acids to the cancer cells. The focus of this editorial is to provide an update on the therapeutic advances being made so far when using these targeted delivery systems.

KW - dendrimer

KW - nanomedicine

KW - transferrin

KW - tumor targeting

KW - gene therapy

UR - http://www.futuremedicine.com/loi/nnm

U2 - 10.2217/nnm.15.93

DO - 10.2217/nnm.15.93

M3 - Article

VL - 10

SP - 2125

EP - 2127

JO - Nanomedicine

JF - Nanomedicine

SN - 1743-5889

IS - 14

ER -